Insurer Seeks To Cover D&O Defenses In DMK Pharma Ch. 11
An insurance company asked a Delaware bankruptcy court Wednesday to let it pay defense expenses under a $5 million directors and officers policy for bankrupt biotechnology company DMK Pharmaceuticals Corp., which...To view the full article, register now.
Already a subscriber? Click here to view full article